The P2Y12 antagonists, 2-methylthioadenosine 5’-monophosphate triethyammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels - Srinivasan, S (J Biol Chem, 2009)